Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estriol for dyspareunia in postmenopausal women
RBR-3y8v57Phase 2Not yet recruiting
- Sponsor
- Faculdade de Medicina de Ribeirão Preto
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of estriol in dyspareunia and vaginal atrophy (3 arms), sponsored by Faculdade de Medicina de Ribeirão Preto. Planned start May 2017; status: not yet recruiting.
02
Drugs
estriol
03
Conditions
dyspareuniavaginal atrophy
Beyond the preview
Go deeper on RBR-3y8v57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3y8v57.